AARTIPHARM
Invest with MTF
Invest Now
Invest in Aarti Pharmalabs with 2.84X leverage
Performance
- Low
- ₹706
- High
- ₹725
- 52 Week Low
- ₹574
- 52 Week High
- ₹971
- Open Price₹717
- Previous Close₹711
- Volume95,480
- 50 DMA₹756.90
- 100 DMA₹772.48
- 200 DMA₹776.56
Investment Returns
- Over 1 Month -9.88%
- Over 3 Month + 1.47%
- Over 6 Month -4.47%
- Over 1 Year + 0.67%
Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!
Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 30.7
- PEG Ratio
- -2.2
- Market Cap Cr
- 6,561
- P/B Ratio
- 3.2
- Average True Range
- 29.11
- EPS
- 23.81
- Dividend Yield
- 0.6
- MACD Signal
- -1.5
- RSI
- 43.09
- MFI
- 38.14
Aarti Pharmalabs Financials
Aarti Pharmalabs Technicals
EMA & SMA
Current Price
₹723.65
+
12.85
(1.81%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹749.70
- 50 Day
- ₹756.90
- 100 Day
- ₹772.48
- 200 Day
- ₹776.56
Resistance and Support
718.2
- R3 748.60
- R2 736.65
- R1 730.15
- S1 711.70
- S2 699.75
- S3 693.25
Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results & Interim Dividend | |
| 2025-11-09 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-10 | Audited Results & Final Dividend | |
| 2025-02-05 | Quarterly Results, Dividend & Others | To consider other business matters. per share(40%)Interim Dividend |
Aarti Pharmalabs F&O
About Aarti Pharmalabs
- NSE Symbol
- AARTIPHARM
- BSE Symbol
- 543748
- Managing Director
- Mr. Narendra J Salvi
- ISIN
- INE0LRU01027
Similar Stocks to Aarti Pharmalabs
Aarti Pharmalabs FAQs
Aarti Pharmalabs share price is ₹723 As on 17 February, 2026 | 22:30
The Market Cap of Aarti Pharmalabs is ₹6560.5 Cr As on 17 February, 2026 | 22:30
The P/E ratio of Aarti Pharmalabs is 30.7 As on 17 February, 2026 | 22:30
The PB ratio of Aarti Pharmalabs is 3.2 As on 17 February, 2026 | 22:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.